FHH-Chr 1BN/Mcwi - Ontology Report

Welcome {{ username}}

Message Center

{{ messageCount }} Messages

Go to Message Center

Watched Genes

{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})

Modify Subscription

Unsubscribe

Watched Ontology Terms

{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})

Modify Subscription

Unsubscribe

{{gene.symbol}}: {{ gene.description }}

Save List to My RGD

Create Name:

Description:

You must be logged in to use this feature

Select categories you would like to watch. Updates to this gene will be sent to {{ username }}

Analyze GeneStrainQTL List

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable
Gene Annotator (Functional Annotation)	Gene Annotator (Annotation Distribution)	Variant Visualizer (Genomic Variants)

InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable
InterViewer (Protein-Protein Interactions)	GViewer (Genome Viewer)	Variant Visualizer (Damaging Variants)

Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
Gene Annotator (Annotation Comparison)	OLGA (Gene List Generator)	Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable
MOET (Multi-Ontology Enrichement)	GOLF (Gene-Ortholog Location Finder)

Send us a Message

Your email

Message

Search RGD Grant Resources Citing RGD About Us Contact Us

Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data

OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)

Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease

Find Models new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive

Pathways

Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

Advanced Search (OLGA)

RAT STRAINS - ANNOTATIONS	{{ watchLinkText }}
The Rat Strain Ontology (RS) is currently being developed at the Rat Genome Database. For more information about this vocabulary or to request additions or changes, please contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:	FHH-Chr 1BN/Mcwi	go back to main search page
Accession:	RS:0000329	browse the term
Synonyms:	related_synonym:	FHH-1BN/Mcwi; RGD ID: 629520

show annotations for term's descendants Sort by:
Rat (2) Mouse (0) Human (0) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
QTL (1) Strains (1)

FHH-Chr 1BN/Mcwi

Symbol

Object Name

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

Rf55

Renal function QTL 55

IEA

RGD

PMID:16303858

RGD:1579884

NCBI chr 1:218,748,008...257,976,495

Related Phenotype Data for Term "FHH-Chr 1BN/Mcwi" (RS:0000329)

Rat Strains:

FHH-Chr 1BN/Mcwi

Clinical Measurements:

absolute change in blood pH
absolute change in body temperature
absolute change in heart rate
absolute change in mean arterial blood pressure
absolute change in partial pressure of blood carbon dioxide
absolute change in partial pressure of blood oxygen
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
arterial blood flow rate
blood eosinophil count
blood hemoglobin level
blood lymphocyte count
blood monocyte count
blood neutrophil count
blood pH
body temperature
body weight
calculated pulmonary vascular resistance normalized to body weight
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50)
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50)
creatinine clearance
dose of methacholine at which pulmonary conductance is half its pretreatment value
FAPGG metabolism-surface area product
fractional change in blood vessel diameter per unit change in intravascular pressure
heart contraction pressure
heart effluent lactate dehydrogenase activity level normalized to heart weight
heart left ventricle infarction weight to total heart left ventricle weight ratio
heart rate
heart right ventricle weight to left ventricle weight ratio
heart weight to body weight ratio
heart wet weight
hematocrit
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
left ventricular developed pressure
left ventricular diastolic blood pressure
left ventricular systolic blood pressure
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50)
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50)
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50)
lung dry weight to body weight ratio
maximum contractile force per wet weight of aorta
mean arterial blood pressure
mean corpuscular hemoglobin
mean corpuscular hemoglobin concentration
mean corpuscular volume
methylene blue metabolism-surface area product after auto-oxidation
methylene blue metabolism-surface area product without auto-oxidation
methylene blue to FAPGG metabolism-surface area product ratio
minute ventilation
partial pressure of blood carbon dioxide (Pco2)
partial pressure of blood oxygen
percent change in arterial blood flow rate
percent change in heart rate
percent change in left ventricular developed pressure
percent change in left ventricular systolic blood pressure
percent change in respiration rate
percent change in tidal volume
percent change in ventilation
plasma anion gap
plasma creatinine level
plasma renin activity level
ratio of change in renal blood flow to change in renal perfusion pressure
red blood cell count
respiration rate
serum alanine aminotransferase activity level
serum albumin level
serum alkaline phosphatase activity level
serum aspartate aminotransferase activity level
serum bicarbonate level
serum calcium level
serum chloride level
serum globulin level
serum glucose level
serum phosphate level
serum potassium level
serum sodium level
serum total bilirubin level
serum total cholesterol level
serum total protein level
serum urea nitrogen level
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel
tidal volume
time to onset of heart contraction
time to peak heart contraction
total white blood cell count
urine albumin excretion rate
urine potassium excretion rate
urine sodium excretion rate
urine total protein excretion rate

Experimental Conditions:

acetylcholine
air carbon dioxide content
control condition
controlled air oxygen content
controlled in situ renal perfusion pressure
controlled NG-nitroarginine methyl ester content drinking water
controlled oxygen content Kreb's solution perfusate
controlled oxygen content physiological salt solution perfusate
controlled sodium content diet
drug dose time series
FAPGG
Kreb's solution perfusate
methacholine
methylene blue
perfusate suspended
phenylephrine
potassium ion
resting on treadmill
running on treadmill
sample resting period
sodium nitroprusside
walking on treadmill

Measurement Methods:

automated blood cell counting method
automated blood gas analysis using a Bayer analyzer
automated plasma creatinine analysis
automated urine total protein analysis
balloon tipped catheter with pressure transducer in isolated perfused heart
digital rectal thermometry
digital scale post excision weight measurement
flame atomic emission spectrometry
fluid-filled catheter with pressure transducer in isolated perfused lung
isolated perfused heart effluent collection
isolated perfused lung vascular effluent collection
microhematocrit tube assay with visual assessment
radioimmunoassay
standard blood chemistry panel
stop flow air displacement plethysmography
ultrasonic flowmeter
urine creatinine analysis
vascular fluid filled catheter
whole body digital scale
wire myography using a Digi-Med tissue force analysis system with force transducer

Term paths to the root

Path 1
Term	Annotations
rat strain	6664
consomic strain	177
FHH-BN/Mcwi Consomics	23
FHH-Chr 1BN/Mcwi	2
Path 2
Term	Annotations
rat strain	6664
chromosome altered	2404
chromosome 1	419
chromosome 1 consomic	8
FHH-Chr 1BN/Mcwi	2

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.

Send us a Message

RAT STRAINS - ANNOTATIONS

Related Phenotype Data for Term "FHH-Chr 1BN/Mcwi" (RS:0000329)